Phreesia (PHR) News

Baird Maintains Neutral on Phreesia, Raises Price Target to $11

Baird analyst Joseph Vruwink maintains Phreesia (NYSE:PHR) with a Neutral and raises the price target from $10 to $11.

BenzingaSep 4 23:01

D.A. Davidson Maintains Phreesia(PHR.US) With Buy Rating, Maintains Target Price $13

D.A. Davidson analyst Clark Wright maintains $Phreesia(PHR.US)$ with a buy rating, and maintains the target price at $13.According to TipRanks data, the analyst has a success rate of 64.9% and a

Futu NewsSep 4 21:31

10-Q: Phreesia | 10-Q: Q2 2027 Earnings Report

SECSep 4 07:14

Express News | Phreesia Inc Files for Mixed Shelf; Size Not Disclosed - SEC Filing

BreakingsSep 4 04:55

Phreesia Shares Sink After 2Q Earnings Underwhelm

By Connor Hart Shares of Phreesia fell after the company reported lower-than-expected earnings during its fiscal second quarter. The stock declined 7.9% to $10.94 Thursday. Shares have lost roughly

WSJSep 4 01:47

Analysts Are Bullish on Top Healthcare Stocks: Climb Bio (CLYM), Phreesia (PHR)

TipRanksSep 4 01:40

D.A. Davidson Maintains Phreesia(PHR.US) With Buy Rating, Cuts Target Price to $13

D.A. Davidson analyst Clark Wright maintains $Phreesia(PHR.US)$ with a buy rating, and adjusts the target price from $14 to $13.According to TipRanks data, the analyst has a success rate of 64.9%

Futu NewsSep 4 00:32

Phreesia's Catalyst for Q3 Is Performance of Network Solutions Business, RBC Says

Phreesia's (PHR) catalyst for Q3 is the performance for its network solutions business, with the company expected to update its full-year guidance during its next earnings report, RBC Capital

MT NewswiresSep 4 00:04

Phreesia Is Maintained at Buy by Freedom Capital Markets

Phreesia Is Maintained at Buy by Freedom Capital

Dow JonesSep 3 23:35

These Analysts Revise Their Forecasts On Phreesia After Q2 Results

Phreesia Inc (NYSE:PHR) on Wednesday reported mixed second-quarter financial results.Phreesia reported quarterly earnings of 3 cents per share which missed the analyst consensus estimate of 10 cents

BenzingaSep 3 22:24

RBC Capital Reiterates Outperform on Phreesia, Maintains $19 Price Target

RBC Capital analyst Ryan Halsted reiterates Phreesia (NYSE:PHR) with a Outperform and maintains $19 price target.

BenzingaSep 3 22:15

Wells Fargo Maintains Equal-Weight on Phreesia, Raises Price Target to $10

Wells Fargo analyst Stan Berenshteyn maintains Phreesia (NYSE:PHR) with a Equal-Weight and raises the price target from $9 to $10.

BenzingaSep 3 22:01

Phreesia Price Target Maintained With a $16.00/Share by Canaccord Genuity

Phreesia Price Target Maintained With a $16.00/Share by Canaccord

Dow JonesSep 3 21:17

Phreesia Is Maintained at Buy by Canaccord Genuity

Phreesia Is Maintained at Buy by Canaccord

Dow JonesSep 3 21:17

Analysts Conflicted on These Healthcare Names: ClearPoint Neuro (CLPT), Hims & Hers Health (HIMS) and Phreesia (PHR)

TipRanksSep 3 21:10

A Quick Look at Today's Ratings for Phreesia(PHR.US), With a Forecast Between $14 to $19

On Sep 03, major Wall Street analysts update their ratings for $Phreesia(PHR.US)$, with price targets ranging from $14 to $19.Needham analyst Ryan MacDonald maintains with a buy rating, and

Futu NewsSep 3 21:00

Phreesia Price Target Maintained With a $14.00/Share by Needham

Phreesia Price Target Maintained With a $14.00/Share by

Dow JonesSep 3 18:02

Analysts Have Conflicting Sentiments on These Healthcare Companies: Phreesia (PHR), Alpha Tau (DRTS) and Fortrea Holdings Inc. (FTRE)

TipRanksSep 3 16:40

Phreesia Earns Buy Rating on Strong Beat, Stabilizing Pharma Business, and Undervalued Asset Profile Highlighted by Weave Deal

TipRanksSep 3 05:45

Transcript: Phreesia Q2 2027 Earnings Conference Call

Phreesia (NYSE:PHR) reported second-quarter financial results on Wednesday. The transcript from the company's second-quarter earnings call has been provided below.This content is powered by Benzinga

BenzingaSep 3 05:31